Methods of treatment using antibodies to IL-17 homologous...

Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S139100, C424S141100, C424S142100, C530S351000

Reexamination Certificate

active

08075888

ABSTRACT:
The present invention is directed to novel polypeptides having sequence identity with IL-17 and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention. Further provided herein are methods for treating degenerative cartilaginous disorders.

REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 6043344 (2000-03-01), Jacobs et al.
patent: 6562578 (2003-05-01), Gorman et al.
patent: 2002/0165348 (2002-11-01), Presnell et al.
patent: 2003/0003545 (2003-01-01), Ebner et al.
patent: 2003/0049255 (2003-03-01), Sims et al.
patent: 2003/0092133 (2003-05-01), Ebner et al.
patent: 2003/0186387 (2003-10-01), Ebner et al.
patent: 2007/0172457 (2007-07-01), Ebner et al.
patent: 2378519 (2001-09-01), None
patent: 2401273 (2001-09-01), None
patent: 2403370 (2001-09-01), None
patent: 2343569 (2003-03-01), None
patent: 1 386 931 (2004-02-01), None
patent: 1 443 055 (2004-08-01), None
patent: 1 326 974 (2006-12-01), None
patent: WO 95/18826 (1995-07-01), None
patent: WO 96/29408 (1996-09-01), None
patent: WO 97/04097 (1997-02-01), None
patent: WO 98/49310 (1998-11-01), None
patent: WO 99/03982 (1999-01-01), None
patent: WO 99/14240 (1999-03-01), None
patent: WO 99/14240 (1999-03-01), None
patent: WO 99/32632 (1999-07-01), None
patent: WO 99/35267 (1999-07-01), None
patent: WO 99/61617 (1999-07-01), None
patent: WO 99/46281 (1999-09-01), None
patent: WO 99/60127 (1999-11-01), None
patent: WO 00/20593 (2000-04-01), None
patent: WO 00/53752 (2000-09-01), None
patent: WO 00/70050 (2000-11-01), None
patent: WO 00/73452 (2000-12-01), None
patent: WO 01/04304 (2001-01-01), None
patent: WO 02/08285 (2001-01-01), None
patent: WO 01/16318 (2001-03-01), None
patent: WO 01/46420 (2001-06-01), None
patent: WO 01/49728 (2001-07-01), None
patent: WO 01/54477 (2001-08-01), None
patent: WO 01/55204 (2001-08-01), None
patent: WO 01/57202 (2001-08-01), None
patent: WO 01/68705 (2001-09-01), None
patent: WO 01/68848 (2001-09-01), None
patent: WO 01/90358 (2001-11-01), None
patent: WO 02/00690 (2002-01-01), None
patent: WO 02/08284 (2002-01-01), None
patent: WO 2004/042009 (2004-05-01), None
patent: WO 2005/000897 (2005-01-01), None
patent: WO 2005/010044 (2005-02-01), None
patent: WO 2006/132788 (2006-12-01), None
U.S. Appl. No. 60/087,340, filed May 29, 1998, Ebner et al.
U.S. Appl. No. 60/099,805, filed Sep. 10, 1998, Ebner et al.
U.S. Appl. No. 60/131,965, filed Apr. 30, 1999, Ebner et al.
Aarvak et al.,“IL-17 Is Produced by Some Proinflammatory Th1/Th0 Cells but not by Th2 Cells” Journal of Immunology 162:1246-1251, (1999).
Aggarwal, et al., The Journal of Biological Chemistry, 278(3): 1910-1914, (2003).
Aggarwal, et al., The Journal of Leukocyte Biology, 71:1-8, (2002).
Albanesi et al.,“IL-17 Is Produced by Nickel-Specific T Lymphocytes and Regulates ICAM-1 Expression and Chemokine Production in Human Keratinocytes: Synergistic or Antagonist Effects with IFN-y and TNF-a” Journal of Immunology 162:494-502, (1999).
Altschul and Gish, “Local Alignment Statistics” Methods in Enzymology 266:460-480, (1996).
Anglade et al., “Interleukin-10 immunoadhesion production by a replication-defective adenovirus,” J. Immunol. Meth. 202:41-48 (1997).
Antonysamy et al., “Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic rejection: cell progenitors” 162(1):577-584, (1999).
Antonysamy, et al., “Evidence for a role of IL-17 in alloimmunity: a novel IL-17 antagonist promotes heart graft survival” Transplant Proc.,31(1-2):93 (1999).
Arend et al, “Cytokines and Cytokine Inhibitors or Antagonists in Rheumatoid Arthritis” Arthritis Rheum. 33:305-315, (1990).
Ashok R. Amin et al., “The role of nitric oxide in articular cartilage breakdown in osteoarthritis” Current Opinion in Rheumatology 10(3) :263-268 (1998).
Attur et al., “Interleukin-17 Up-Regulation of Nitric Oxide Production in Human Osteoarthritis Cartilage” Arthritis and Rheumatism 40(6):1050-1053, (Jun. 1997).
Awane et al., “NF-KB-Inducing Kinase is a Common Mediator of IL-17-TNF-a and IL-1P-Induced Chemokine Promoter Activation in Intestinal Epithelial Cells” J. Immunol 162:5337-5344, (1999).
Becher, et al., The Journal of Clinical Investigation, 110(4):493-497, (2002).
Becher, et al., The Journal of Clinical Investigation, 112(8):1186-1191, (2003).
Biesinger et al., “Stable growth transformation of human T lymphocytes by Herpesvirus saimiri”proc, Natl. Acad. Sci. USA89:3116-3119, (1992).
Broxmeyer, H.E., “Is Interleukin 17, An Inducible Cytokine That Stimulates Production of Other Cytokines, Merely a Redundant Player in a Sea of Other Biomolecules?” Journal of Experimental Medicine 183:2411-2415, (Jun. 1996).
Burchill, et al., Infection and Immunity, 71(6):3437-3442, (2003).
Bush, et al, Arthritis & Rheumatism, 46(2):802-805, (2002).
Chabaud et al., “Enhancing Effect of IL-17 on IL-1-Induced IL-6 and Leukemia Inhibitory Factor Production by Rheumatoid Arthritis Synoviocytes and Its Regulation by Th2 Cytokines” Journal of Immunology 161:409-414, (1998).
Chabaud et al., “Human Interleukin-17: A T Cell-Derived Proinflammatory Cytokine Produced by the Rheumatoid Synovium” Arthrtis & Rheumatism 42(5):963-970, (1999).
Constantinescu, et al., The journal of Immunology, 161:5097-5104, (1998).
Cua, et al., Letters to Nature, 421:744-748, (2003).
Database EMBL, “Homo sapienschromosome 3 clone RP11-1020A11 map 3p, complete sequence”, Accession No. AC018809, Dec. 23, 1999.
Database EMBL, “Homo sapiensIL-17 receptor homolog precursor (EVI27) mRNA, complete cds”, Accession No. AF208110, Jul. 18, 2000.
Database EMBL, “Homo sapiensIL-17RE mRNA, complete cds”, Accession No. AF458069, Aug. 12, 2002.
Database Uniprot, “Interleukin-17 receptor B precursor (IL-17 receptor B) (IL-17RB) (Interleukin-17B receptor) (IL-17B receptor) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (Cytokine receptor CRL4)”, Accession No. Q9NRM6, May 27, 2002.
Database Uniprot, “Interleukin-17 receptor E precursor (IL-17 receptor E) (IL-17RE)”, Accession No. Q8NFR9, Oct. 1, 2002.
Database Uniprot, “Uncharacterized protein IL 17RE (Fragment)”, Accession No. A6NL85, Jul. 24, 2007.
Dubowchik, et al., Pharmacology & Therapeutics, 83:67-123, (1999).
Ely, et al., Nature Immunology, vol. 10, No. 12, pp. 1245-1252, (2009).
Farndale et al., “Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue” Biochem. Biophys. Acta 883:173-177, (1986).
Fleckenstein and Desrosiers, “Herpesvirus saimiri and herpesvirus ateles” In the Hernesviruses I.B. Roizman, ed., NY:Plenum Publishing Press pp. 253-332, (1982).
Fleit, et al., Journal of Leukocyte Biology, 49: 556-565, (1991).
Fossiez at al., “Interleukin-f7” Int. Rev. Immunol.16(5-6):541-551, (1998).
Fossiez et al., “T Cell Interleukin-17 Induces Stromal Cells to Produce Proinflammatory and Hematopoietic Cytokines” Journal of Experimental Medicine 183(6):2593-2603, (1996).
Genbank, Accession No. AL132, (Nov. 15, 1999).
Goodin, et al., Neurology, 58:169-174, (2001).
Gordon et al., “Molecular immunobiology of macrophages: recent progress” Current Opinion in Immunology 7:24-33, (1995).
Haak, et al., The Journal of Clinical Investigation, 119(1):61-69, (2009).
Hillier et al., “af37c02.s1 Soares total fetus Nb2HF8 9wHomo sapienscDNA clone 1033826 3′” (Accession No. AA780147), (Feb. 6, 1998).
Hillier et al., “The WashU Merck EST Project”

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of treatment using antibodies to IL-17 homologous... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of treatment using antibodies to IL-17 homologous..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treatment using antibodies to IL-17 homologous... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4259122

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.